Pharmaceutical News

Separately, analysts at RBC Capital (NYSE: RY) upgraded shares of Auxilium Pharma from a “sector perform” rating to an “outperform” rating in a research note to investors on Wednesday.

An investigator for the state’s Office of Inspector General, Jones uncovered payments from pharmaceutical companies to state officials in exchange for favorable treatment of their antipsychotic drugs in state medical programs.

Boston-based startup Ember Therapeutics scored new data on its brown fat program to take into partnership talks at the J.P. Morgan conference this week in San Francisco, giving the young biotech's executives proof that its early-stage work could lead to breakthrough drugs for obesity and type 2 diabetes.